biotin has been researched along with Recrudescence in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cohen, JA; Goldschmidt, CH | 1 |
Berger, E; Bourre, B; Camdessanche, JP; Castelnovo, G; Ciron, J; Clavelou, P; De Seze, J; Defer, G; Dulau, C; Edan, G; Gout, O; Guennoc, AM; Heinzlef, O; Labauge, P; Laplaud, D; Lebrun-Frenay, C; Magy, L; Maillart, E; Mathais, S; Mathey, G; Moisset, X; Moreau, T; Pelletier, J; Pereira, B; Taithe, F; Vermersch, P; Vukusic, S | 1 |
Brandao, GM; Junqueira, DR; Rollo, HA; Sobreira, ML | 1 |
Blanchemain, N; Chai, F; Haulon, S; Maton, M; Maurel, B | 1 |
Cansever, MS; Kiykim, A; Kiykim, E; Zeybek, CA | 1 |
1 review(s) available for biotin and Recrudescence
Article | Year |
---|---|
Pentasaccharides for the treatment of deep vein thrombosis.
Topics: Anticoagulants; Biotin; Fondaparinux; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Oligosaccharides; Polysaccharides; Randomized Controlled Trials as Topic; Recurrence; Time Factors; Venous Thrombosis | 2017 |
1 trial(s) available for biotin and Recrudescence
Article | Year |
---|---|
Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis.
Topics: Adult; Aged; Anticoagulants; Biotin; Blood Coagulation; Double-Blind Method; Drug Administration Schedule; Europe; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Injections, Subcutaneous; Male; Middle Aged; Oligosaccharides; Recurrence; Risk Assessment; Time Factors; Treatment Outcome; United States; Venous Thrombosis | 2011 |
4 other study(ies) available for biotin and Recrudescence
Article | Year |
---|---|
The Rise and Fall of High-Dose Biotin to Treat Progressive Multiple Sclerosis.
Topics: Biotin; Humans; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Propensity Score; Prospective Studies; Recurrence | 2020 |
Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis.
Topics: Adult; Biotin; Case-Control Studies; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Recurrence; Retrospective Studies | 2021 |
In stent restenosis and thrombosis assessment after EP224283 injection in a rat model.
Topics: Angioplasty, Balloon; Animals; Aorta; Biotin; Cell Proliferation; Disease Models, Animal; Factor XI; Graft Occlusion, Vascular; Male; Muscle, Smooth, Vascular; Neointima; Oligosaccharides; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Wistar; Recurrence; Stents; Thrombosis | 2013 |
Biotinidase deficiency mimicking primary immune deficiencies.
Topics: Biotin; Biotinidase Deficiency; Candidiasis; Child, Preschool; Consanguinity; Dermatitis; Female; Hearing Loss, Sensorineural; Humans; Mouth Diseases; Recurrence; Respiratory Tract Infections; Turkey | 2015 |